Anatara Lifesciences Ltd (AU:ANR) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Anatara Lifesciences Ltd has successfully raised $660,000 through a share placement and announced a Share Purchase Plan aiming to raise an additional $500,000. The funds will support the completion of a crucial Phase II clinical study for their GaRP medication, targeting irritable bowel syndrome, and advance an anti-obesity project. This financial move reflects strong investor confidence in Anatara’s innovative solutions for gastrointestinal diseases.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.